Furthermore, Kaplan‒Meier survival curves revealed that high expression of FLT3LG in NSCLC patients was associated with improved overall survival (OS) and first progression (FP) (Fig. 2c and d). This evidence concerns the gene FLT3LG and non-small cell lung carcinoma.